The U.S. diabetes market is undergoing a rapid transformation, fueled by technological innovation, rising obesity rates, and growing demand for smarter, more personalized treatment options. Valued at nearly $48 billion in 2024, the U.S. market for diabetes monitoring, treatment, and drug delivery is forecasted to reach $79 billion by 2031. For investors, the space presents [...]The post U.S. Diabetes Market Size And Growth: What Investors Need to Know in 2025 appeared first on iData Research.